Literature DB >> 29963389

Endoscopic Port AccessTM left ventricle outflow tract resection and atrioventricular valve surgery.

Johan van der Merwe1, Filip Casselman1, Frank Van Praet1.   

Abstract

The continuous evolution in robotic-, endoscopic- and trans-catheter cardiac interventions resulted in innovative techniques that simultaneously address left ventricular outflow tract obstruction (LVOTO) and concomitant atrioventricular valve (AVV) pathology in the context of hypertrophic obstructive cardiomyopathy (HOCM). We present our brief report of 13 consecutive HOCM patients with concomitant AVV disease, who underwent endoscopic left ventricular septal myomectomy (LVSM) and AVV surgery by Endoscopic Port AccessTM Surgery (EPAS) between March 1st 2010 and October 31st 2015. Our EPAS technique in the context of HOCM utilizes peripheral cardiopulmonary bypass, endo-aortic balloon occlusion and a 4-cm right antero-lateral thoracic working port. Access to the LVOTO is obtained by detaching the anterior mitral valve (MV) leaflet from the annulus. Controlled sharp LVSM is then performed from the aortic leaflet base to the papillary muscles. Subsequent routine AVV surgery is performed using long shafted instruments. There were no sternotomy conversions, LVSM complications or 30-day mortalities. The mean length of hospitalization was 17.7±18.1 days. Long-term clinical and echocardiographic analysis of 645.7 patient-months (n=13, 100.0% complete) identified two late mortalities, which were not procedure-, HOCM- or AVV-related. All patients (n=13, 100.0%), including the late mortalities, had significant improvement in their quality of life, a 100% long-term freedom from re-intervention and no residual peak instantaneous LVOTO gradients more than 15 mmHg. This brief report emphasises that simultaneous LVSM and concomitant AVV surgery by EPAS can safely be performed in experienced centres with favourable long-term outcomes.

Entities:  

Keywords:  Minimally invasive port access surgery; hypertrophic obstructive cardiomyopathy (HOCM); mitral and tricuspid valve diseases (MV and TV diseases); outcome

Year:  2018        PMID: 29963389      PMCID: PMC5994454          DOI: 10.21037/jovs.2018.05.01

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  19 in total

1.  Transesophageal echocardiography for port-access surgery.

Authors:  J Coddens; T Deloof; J Hendrickx; H Vanermen
Journal:  J Cardiothorac Vasc Anesth       Date:  1999-10       Impact factor: 2.628

2.  Late redo-port access surgery after port access surgery.

Authors:  Johan van der Merwe; Filip Casselman; Bernard Stockman; Yvette Vermeulen; Ivan Degrieck; Frank Van Praet
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-10-13

3.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Steve R Ommen; Barry J Maron; Iacopo Olivotto; Martin S Maron; Franco Cecchi; Sandro Betocchi; Bernard J Gersh; Michael J Ackerman; Robert B McCully; Joseph A Dearani; Hartzell V Schaff; Gordon K Danielson; A Jamil Tajik; Rick A Nishimura
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

Review 4.  Robotic trans-atrial and trans-mitral ventricular septal resection.

Authors:  W Randolph Chitwood
Journal:  Ann Cardiothorac Surg       Date:  2017-01

5.  Endoscopic mitral valve repair: feasible, reproducible, and durable.

Authors:  Filip P Casselman; Sam Van Slycke; Helge Dom; Dave L Lambrechts; Yvette Vermeulen; Hugo Vanermen
Journal:  J Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 5.209

6.  Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy.

Authors:  Nicholas G Smedira; Bruce W Lytle; Harry M Lever; Jeevanantham Rajeswaran; Gita Krishnaswamy; Ryan K Kaple; Diana O W Dolney; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2008-01       Impact factor: 4.330

7.  Endoscopic atrioventricular valve surgery in adults with difficult-to-access uncorrected congenital chest wall deformities.

Authors:  Johan van der Merwe; Filip Casselman; Bernard Stockman; Yvette Vermeulen; Ivan Degrieck; Frank Van Praet
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-08-19

8.  Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  R C Robbins; E B Stinson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

9.  First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Authors:  Paul Sorajja; Wesley A Pedersen; Richard Bae; John R Lesser; Desmond Jay; David Lin; Kevin Harris; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2016-06-21       Impact factor: 24.094

10.  Endoscopic mitral and tricuspid valve surgery after previous cardiac surgery.

Authors:  Filip P Casselman; Mark La Meir; Hughes Jeanmart; Enzo Mazzarro; Jose Coddens; Frank Van Praet; Francis Wellens; Yvette Vermeulen; Hugo Vanermen
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

View more
  1 in total

1.  Early results of optimal septal myectomy using 3-dimensional printed models.

Authors:  Uladzimir Andrushchuk; Vitali Adzintsou; Artsem Niavyhlas; Hanna Model; Youry Ostrovsky
Journal:  Kardiochir Torakochirurgia Pol       Date:  2019-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.